Monthly News Roundup – December 2013

Sovaldi: Breakthrough Therapy Approved for Hepatitis C Virus The U.S. Food and Drug Administration has approved Gilead’s Sovaldi (sofosbuvir) to treat chronic hepatitis C virus (HCV) infection. Sovaldi is part of a new paradigm of treatment, used in combination with...

Electromed stock leaps as FDA approves new product

It’s still Christmas for New Prague-based Electromed Inc., whose stock more than doubled Monday after the government approved the medical device company’s first new product since 2006. The stock of 90-employee Electromed rose $1.08, or nearly 107 percent, to $2.09 a...